MSD Europe

Despite robust evidence that investing in health generates long-term benefits including economic growth and healthy productive societies, macroeconomic and demographic pressures see #EU Member States targeting #healthcare budgets to address public funding shortfalls. 🎧 In this Vital Health podcast, Bordignon Massimo, Herwig OSTERMANN and Prof. Dr. Dennis Ostwald discuss how new budgeting models, evidence and metrics on return on investment could deliver more efficient outcomes and healthier societies. ⬇️ https://lnkd.in/escKhkrm #FutureOfHealth #Innovation #Healthcare

At MSD, we believe in the power of vaccines to build a healthier and better-protected world. 🌍 We have championed vaccine research for decades, helping to protect millions from vaccine-preventable diseases across the life course. As we continue to innovate in 2025 and beyond, our mission is to deliver innovative health solutions that advance disease prevention and treatment for people of all ages everywhere. 🔬 Find out more on our vision: https://bit.ly/3wlZZzN

In 2025, we will continue working together to improve health outcomes for all Europeans. Our commitment to improve and save lives through continuous innovation remains stronger than ever. We wish everyone better health, more innovation, and brighter days. Happy New Year!🎉 #NewYear2025

Every woman should have equal access to cancer prevention, screening, and care, but this is not the reality yet. 🔙 In an article published by Euractiv earlier this year, MSD Senior Vice President, Louise Houson, highlighted the disparities women face in accessing cancer care in Europe and across the world. As a company committed to bringing quality cancer care to more women who need it, MSD collaborates with several initiatives and organizations around the world in an effort to ensure all women, regardless of where they are from, have the best possible chance of surviving cancer. 📰 Read it here: https://lnkd.in/eCqT3AxW #Throwback #Cancer #Oncology

The impact of vaccination campaigns is clear.     Collaborative efforts on immunisation have significantly reduced the impact of disease, demonstrating the effectiveness of united health actions. 📉     At MSD, we continue to measure success not just in doses distributed, but in the futures of people secured. Find out more, here: https://bit.ly/3wlZZzN     #WeAreMSDVaccines #Immunisation #Vaccines 

A few weeks ago, our MSD team attended the European Cancer Organisation Summit, where we listened to powerful patient testimonials on the importance of HPV prevention. We also discussed challenges and opportunities across Europe, such as engaging healthcare professionals, community leaders, and ensuring political commitments. This year, we've seen remarkable progress with the Council recommendation to combat vaccine-preventable cancers and its implementation. More countries are committing to the elimination of cervical cancer, breaking down barriers to prevention, and using data to guide decision-making. 2025 is set to mark a pivotal year for health policy in the EU, with the potential to shape the future of healthcare for Europeans in the coming decades. Cancer prevention and care, in particular, should be at the top of the political agenda. #Throwback #CervicalCancer #CancerCare #EU

💡 From aging populations and non-communicable diseases (#NCDs) to data-driven health innovations. In the new Vital Health podcast "𝐀𝐝𝐝𝐫𝐞𝐬𝐬𝐢𝐧𝐠 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐇𝐞𝐚𝐥𝐭𝐡 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬: 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧, 𝐏𝐫𝐞𝐯𝐞𝐧𝐭𝐢𝐨𝐧, 𝐚𝐧𝐝 𝐏𝐨𝐥𝐢𝐜𝐲", Annemiek Verkamman, Francesca Colombo and Josep Figueras explore how policy, technology, and cross-border collaboration can enhance Europe's healthcare resilience. 🎧 Listen now for a deep dive into the future of health in #Europe ⬇️ https://lnkd.in/eNC9pqiE #FutureOfHealth #Innovation #Healthcare

Endometrial cancer prevention deserves a bigger spotlight in public health campaigns. 🔦   Nurses and healthcare professionals play a key role in promoting healthy habits - maintaining a balanced weight, adopting nutritious diets, and staying active - all essential steps to help reduce the risk of this cancer.   💡 Insights from a new report by IHE - The Swedish Institute for Health Economics, endorsed by EONS and ENGAGe, reveals that endometrial cancer doesn’t receive the focus it needs compared to other women’s cancers. The report calls for action to raise awareness and improve care, laying out key recommendations: 🎗️ Raise awareness ❤️🩹 Provide patient-centred support and information 🚑 Ensure optimal care delivery 🔬 Foster research 🟰 Reduce health disparities   Read the full report, “Endometrial Cancer-Improving Care and Driving Policy Change” here: https://lnkd.in/dsXPUtaP   #WomensCancers #EndometrialCancer

🩺 Early detection of endometrial cancer is a game-changer—for both patients and healthcare systems. When caught early, cancer care costs are significantly lower, with early-stage care costing half as much as late-stage care!   As endometrial cancer rates rise, driven by increasing obesity rates, we need to prioritise prevention and early detection. These strategies not only save costs but, most importantly, improve patient outcomes. 💡✨   The recent study by IHE - The Swedish Institute for Health Economics (IHE) on “Endometrial Cancer-Improving Care and Driving Policy Change” emphasises the need for early detection to reduce costs, leading to less complex treatments and better outcomes for patients.   💡Read the full report, here: https://lnkd.in/dsXPUtaP   #WomensCancers #EndometrialCancer #GynaecologicalCancer